The forecast for the insulin dosage market size value per capita in Austria shows a slight annual decrease over the forecast period from 2024 to 2028. In 2024, the value is projected to be $10.76, declining marginally each year to $10.72 by 2028.
In 2023, the actual market size value per capita was slightly above the forecasted value for 2024.
The year-on-year percentage variation from 2024 to 2028 is relatively small, indicating a steady and gradual decline. The constant annual decrease over the past years reflects a small downward trend. The Compound Annual Growth Rate (CAGR) over the last five years is negative but very small, reinforcing the stability of this downward trend.
Future trends to watch for:
- Potential advancements in diabetes management and treatment technology, which could impact the insulin market.
- Policy changes regarding healthcare funding and diabetes management in Austria.
- Fluctuations in the diabetic population and their healthcare needs.
